Skip to main content
☰
moat
keep
Markets
News
Screener
Research
Editorials
Pricing
About
⌘K
Sign in
Start free
QIAGEN N.V. (QGEN) stock — financials, valuation and filings | Moatkeep
Companies
/
NYSE
/
QGEN
QIAGEN N.V.
QGEN · NYSE
$41.88
−1.46%
Close, 2026-09-14
Close, 2026-09-14 · source: Databento · USD · figures not investment advice
+ Alert
★ Watchlist
Overview
News
Valuation
Financials
Reports
Editorials & Research
Business
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MAX
⤢ Expand
Price
▾
Log
Volume
Events
▾
Window
-29.5%
vs low
+28.1%
vs high
-33.2%
Price
through 2026-09-14
ex-date (0) · fiscal quarter (0)
Dividends: company filings (SEC EDGAR) and the historical exchange record.
State of incorporation
P7
Fiscal year end
Dec 31
Financials · five years
Investor
Revenue
•••••
•••••
•••••
Gross profit
•••••
•••••
•••••
Operating income
•••••
•••••
•••••
Net income
•••••
•••••
•••••
Free cash flow
•••••
•••••
•••••
Investor
Read the full financial statements
Free accounts read five years of annual financials.
Create a free account
Source: SEC EDGAR (XBRL) · figures in USD millions
View full financials →
Related companies
SFD
—
SMITHFIELD FOODS INC
PRMB
—
Primo Brands Corp
SOLS
—
Solstice Advanced Materials Inc.
IONS
—
IONIS PHARMACEUTICALS INC
KYMR
—
Kymera Therapeutics, Inc.
TKR
—
TIMKEN CO
GIL
—
Gildan Activewear Inc.
PCVX
—
Vaxcyte, Inc.